Literature DB >> 16455601

Temperature stability and bioadhesive properties of delta9-tetrahydrocannabinol incorporated hydroxypropylcellulose polymer matrix systems.

Michael A Repka1, Mahmoud A ElSohly, Manish Munjal, Samir A Ross.   

Abstract

The purpose of this study was to determine and compare the bioadhesive profiles of hydroxypropylcellulose (HPC) polymer matrices as a function of delta9-tetrahydrocannabinol (THC) content. In addition, the effect of processing temperature on the stability of THC and its extent of degradation to cannabinol (CBN) was investigated. A hot-melt cast molding method was used to prepare HPC polymer matrix systems incorporated with THC at 0, 4, 8, and 16 percent. Bioadhesive measurements including peak adhesive force, area under the curve, and elongation at adhesive failure were recorded utilizing the TA.XT2i Texture Analyzer. Data obtained from these tests at various contact time intervals suggested that the incorporation of THC led to an increase in the bioadhesive strength of the HPC polymer matrices. To determine the stability of THC and the resulting CBN content in the matrices, three different processing temperatures were utilized (120, 160, and 200 degrees C). Post-production High Performance Liquid Chromotography (HPLC) analysis revealed that the processed systems contained at least 94% of THC and the relative percent formation of CBN was 0.5% at 120 degrees C and 0.4% at 160 degrees C compared to 1.6% at 200 degrees C. These findings indicate that the cannabinoid may be a plausible candidate for incorporation into systems utilizing hot-melt extrusion techniques for the development of an effective mucoadhesive transmucosal matrix system for delivery of THC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455601      PMCID: PMC2921171          DOI: 10.1080/03639040500387914

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  23 in total

1.  The stability of cannabis and its preparations on storage.

Authors:  J W Fairbairn; J A Liebmann; M G Rowan
Journal:  J Pharm Pharmacol       Date:  1976-01       Impact factor: 3.765

2.  Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.

Authors:  M A ElSohly; D F Stanford; E C Harland; A H Hikal; L A Walker; T L Little; J N Rider; A B Jones
Journal:  J Pharm Sci       Date:  1991-10       Impact factor: 3.534

3.  Stability of cannabinoids in dried samples of cannabis dating from around 1896-1905.

Authors:  D J Harvey
Journal:  J Ethnopharmacol       Date:  1990-02       Impact factor: 4.360

4.  Constituents of Cannabis sativa L. IV. Stability of cannabinoids in stored plant material.

Authors:  C E Turner; K W Hadley; P S Fetterman; N J Doorenbos; M W Quimby; C Waller
Journal:  J Pharm Sci       Date:  1973-10       Impact factor: 3.534

5.  Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey.

Authors:  E Perlin; C G Smith; A I Nichols; R Almirez; K P Flora; J C Cradock; C C Peck
Journal:  J Pharm Sci       Date:  1985-02       Impact factor: 3.534

6.  Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion.

Authors:  M A Repka; J W McGinity
Journal:  J Control Release       Date:  2001-02-23       Impact factor: 9.776

7.  Effects of concentration and volume on nasal bioavailability and biological response to desmopressin.

Authors:  A S Harris; M Ohlin; S Lethagen; I M Nilsson
Journal:  J Pharm Sci       Date:  1988-04       Impact factor: 3.534

8.  Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.

Authors:  A Ohlsson; J E Lindgren; A Wahlen; S Agurell; L E Hollister; H K Gillespie
Journal:  Clin Pharmacol Ther       Date:  1980-09       Impact factor: 6.875

9.  Constituents of Cannabis sativa L. XIII: Stability of dosage form prepared by impregnating synthetic (--)-delta 9-trans-tetrahydrocannabinol on placebo Cannabis plant material.

Authors:  G S Lewis; C E Turner
Journal:  J Pharm Sci       Date:  1978-06       Impact factor: 3.534

10.  Determination of delta 9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatography.

Authors:  K P Flora; J C Cradock; J P Davignon
Journal:  J Chromatogr       Date:  1981-02-06
View more
  12 in total

1.  Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.

Authors:  Ketan Hippalgaonkar; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

2.  Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.

Authors:  Sampada B Upadhye; Swapnil J Kulkarni; Soumyajit Majumdar; Mitchell A Avery; Waseem Gul; Mahmoud A ElSohly; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

3.  Cannabis with breast cancer treatment: propitious or pernicious?

Authors:  Recardia Schoeman; Amy de la Harpe; Natasha Beukes; Carminita L Frost
Journal:  3 Biotech       Date:  2022-02-01       Impact factor: 2.406

4.  Influence of processing parameters and formulation factors on the bioadhesive, temperature stability and drug release properties of hot-melt extruded films containing miconazole.

Authors:  Meiwan Chen; Jiannan Lu; Weibin Deng; Abhilasha Singh; Noorullah Naqvi Mohammed; Michael A Repka; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2014-02-19       Impact factor: 3.246

Review 5.  Applications of hot-melt extrusion for drug delivery.

Authors:  Michael A Repka; Soumyajit Majumdar; Sunil Kumar Battu; Ramesh Srirangam; Sampada B Upadhye
Journal:  Expert Opin Drug Deliv       Date:  2008-12       Impact factor: 6.648

6.  Chemical stability and bioadhesive properties of an ester prodrug of Delta 9-tetrahydrocannabinol in poly(ethylene oxide) matrices: effect of formulation additives.

Authors:  Sridhar Thumma; Soumyajit Majumdar; Mahmoud A ElSohly; Waseem Gul; Michael A Repka
Journal:  Int J Pharm       Date:  2008-07-05       Impact factor: 5.875

7.  A new strategy to enhance artificial ligament graft osseointegration in the bone tunnel using hydroxypropylcellulose.

Authors:  Jianjun Yang; Jia Jiang; Yuzhuo Li; Hong Li; Ying Jing; Peiyi Wu; Dong Yu; Shiyi Chen
Journal:  Int Orthop       Date:  2012-11-25       Impact factor: 3.075

8.  Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol.

Authors:  Nagendra S Punyamurthula; Tushar Hingorani; Goutham Adelli; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  Drug Dev Ind Pharm       Date:  2015-12-07       Impact factor: 3.225

Review 9.  Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.

Authors:  Arun Radhakrishnan; Gowthamarajan Kuppusamy; Sivasankaran Ponnusankar; Nikhitha K Shanmukhan
Journal:  Pharmacogenomics J       Date:  2019-12-10       Impact factor: 3.550

10.  Delta9-THC determination by the EU official method: evaluation of measurement uncertainty and compliance assessment of hemp samples.

Authors:  Salvatore Sgrò; Benedicta Lavezzi; Cristian Caprari; Marco Polito; Marcello D'Elia; Giampietro Lago; Giada Furlan; Stefano Girotti; Elida Nora Ferri
Journal:  Anal Bioanal Chem       Date:  2021-03-23       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.